Trial intelligence / Profile preview

PH-10 and Photodynamic Therapy in Plaque Psoriasis

NCT00555646Phase 2Terminated

Sponsor
Provectus Biopharmaceuticals
Start
Nov 2007
Primary completion
Sep 2008
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of rose bengal in plaque psoriasis, sponsored by Provectus Biopharmaceuticals. Started Nov 2007; status: terminated.

02

Drugs

rose bengal
03

Conditions

plaque psoriasis

Beyond the preview

Go deeper on NCT00555646.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00555646.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call